Mackenzie Financial Portfolio holdings
AUM
$77.2B
1-Year Return
22.51%
This Quarter Return
-20.33%
1 Year Return
+22.51%
3 Year Return
+61.14%
5 Year Return
+128.52%
10 Year Return
+216.87%
AUM
$31.1B
AUM Growth
-$9.66B
(-24%)
Cap. Flow
+$45.5M
Cap. Flow
% of AUM
0.15%
Top 10 Holdings %
Top 10 Hldgs %
22.17%
Holding
1,220
New
148
Increased
491
Reduced
402
Closed
154
Top Buys
| 1 |
Becton Dickinson
BDX
|
+$259M |
| 2 |
Procter & Gamble
PG
|
+$163M |
| 3 |
Synopsys
SNPS
|
+$146M |
| 4 |
Brookfield
BN
|
+$139M |
| 5 |
S&P Global
SPGI
|
+$136M |
Top Sells
| 1 |
Visa
V
|
+$271M |
| 2 |
Stryker
SYK
|
+$186M |
| 3 |
Bank of Montreal
BMO
|
+$163M |
| 4 |
DexCom
DXCM
|
+$141M |
| 5 |
Thermo Fisher Scientific
TMO
|
+$135M |
Sector Composition
| 1 | Financials | 23.87% |
| 2 | Technology | 14.72% |
| 3 | Industrials | 11.69% |
| 4 | Healthcare | 11.36% |
| 5 | Consumer Discretionary | 6.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
751
Ziff Davis
ZD
$1.5B
| $665K | ﹤0.01% |
10,221
-48,431
| -83% | -$3.15M |
|
752
NovaGold Resources
NG
$2.69B
| $660K | ﹤0.01% |
90,190
-7,723
| -8% | -$56.5K |
|
753
Constellium
CSTM
$2.02B
| $659K | ﹤0.01% |
126,400
| – | – |
|
754
InMode
INMD
$949M
| $654K | ﹤0.01% |
60,840
-22,542
| -27% | -$242K |
|
755
Neurocrine Biosciences
NBIX
$14B
| $652K | ﹤0.01% |
7,535
-46
| -0.6% | -$3.98K |
|
756
NorthWestern Energy
NWE
$3.47B
| $649K | ﹤0.01% |
10,840
-4,826
| -31% | -$289K |
|
757
Domino's
DPZ
$15.3B
| $636K | ﹤0.01% |
1,961
+131
| +7% | +$42.5K |
|
758
Nexstar Media Group
NXST
$5.98B
| $636K | ﹤0.01% |
11,021
-98
| -0.9% | -$5.66K |
|
759
Analog Devices
ADI
$122B
| $635K | ﹤0.01% |
7,085
+1,095
| +18% | +$98.1K |
|
760
FTI Consulting
FCN
$5.23B
| $635K | ﹤0.01% |
5,300
-2,150
| -29% | -$258K |
|
761
GATX Corp
GATX
$6B
| $632K | ﹤0.01% |
10,100
-2,800
| -22% | -$175K |
|
|
GSV
762
DELISTED
Gold Standard Ventures Corp.
GSV
| $632K | ﹤0.01% |
1,299,700
| – | – |
|
763
O'Reilly Automotive
ORLY
$89.2B
| $629K | ﹤0.01% |
31,320
+3,630
| +13% | +$72.9K |
|
764
UGI
UGI
$7.38B
| $627K | ﹤0.01% |
23,494
+16,560
| +239% | +$442K |
|
765
Voya Financial
VOYA
$7.3B
| $626K | ﹤0.01% |
15,450
-14,250
| -48% | -$577K |
|
766
LPL Financial
LPLA
$27.4B
| $625K | ﹤0.01% |
11,477
+201
| +2% | +$10.9K |
|
767
Haemonetics
HAE
$2.59B
| $624K | ﹤0.01% |
6,262
+762
| +14% | +$75.9K |
|
768
Amneal Pharmaceuticals
AMRX
$3.08B
| $619K | ﹤0.01% |
+177,878
| New | +$619K |
|
|
EFC
769
Ellington Financial
EFC
$1.36B
| $618K | ﹤0.01% |
108,234
-2,814
| -3% | -$16.1K |
|
770
Mersana Therapeutics
MRSN
$36.7M
| $617K | ﹤0.01% |
+4,231
| New | +$617K |
|
771
FedEx
FDX
$53.3B
| $616K | ﹤0.01% |
5,081
+721
| +17% | +$87.4K |
|
772
Global Net Lease
GNL
$1.81B
| $614K | ﹤0.01% |
45,950
| – | – |
|
773
Essential Properties Realty Trust
EPRT
$5.88B
| $610K | ﹤0.01% |
46,708
-17,945
| -28% | -$234K |
|
774
Cincinnati Financial
CINF
$23.8B
| $608K | ﹤0.01% |
8,054
-880
| -10% | -$66.4K |
|
775
OR Royalties Inc.
OR
$6.69B
| $604K | ﹤0.01% |
81,573
-69,285
| -46% | -$513K |
|